Neumora Therapeutics is trading 5.1% up at $0.49 after-hours on October 6, with no verified company-specific announcement identified to explain the move. - Shares fell 10.34% during the regular session, closing at $0.47. - Available company news results show earlier updates rather than a clear October 6 catalyst; the available information does not establish a cause for the extended-hours rise.